Cargando…

High-density transposon libraries utilising outward-oriented promoters identify mechanisms of action and resistance to antimicrobials

The use of bacterial transposon mutant libraries in phenotypic screens is a well-established technique for determining which genes are essential or advantageous for growth in conditions of interest. Standard, inactivating, transposon libraries cannot give direct information about genes whose over-ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Coward, Chris, Dharmalingham, Gopujara, Abdulle, Omar, Avis, Tim, Beisken, Stephan, Breidenstein, Elena, Carli, Natasha, Figueiredo, Luis, Jones, David, Khan, Nawaz, Malara, Sara, Martins, Joana, Nagalingam, Nabeetha, Turner, Keith, Wain, John, Williams, David, Powell, David, Mason, Clive
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735965/
https://www.ncbi.nlm.nih.gov/pubmed/33186989
http://dx.doi.org/10.1093/femsle/fnaa185
Descripción
Sumario:The use of bacterial transposon mutant libraries in phenotypic screens is a well-established technique for determining which genes are essential or advantageous for growth in conditions of interest. Standard, inactivating, transposon libraries cannot give direct information about genes whose over-expression gives a selective advantage. We report the development of a system wherein outward-oriented promoters are included in mini-transposons, generation of transposon mutant libraries in Escherichia coli and Pseudomonas aeruginosa and their use to probe genes important for growth under selection with the antimicrobial fosfomycin, and a recently-developed leucyl-tRNA synthase inhibitor. In addition to the identification of known mechanisms of action and resistance, we identify the carbon–phosphorous lyase complex as a potential resistance liability for fosfomycin in E. coli and P. aeruginosa. The use of this technology can facilitate the development of novel mechanism-of-action antimicrobials that are urgently required to combat the increasing threat worldwide from antimicrobial-resistant pathogenic bacteria.